Unveiling CYP450 inhibition by the pesticide prothioconazole through integrated in vitro studies and PBPK modeling
- 20 April 2025
- journal article
- toxicokinetics and-metabolism
- Published by Springer Nature in Archives of Toxicology
- Vol. 99 (7) , 2845-2854
Abstract
Prothioconazole (PTC), a widely used triazole fungicide with low human toxicity, was evaluated for its potential to inhibit human cytochrome P450 (CYP450) enzymes and its implications for pesticide-drug interactions (PDI). Through in vitro assays, PTC demonstrated significant inhibition of CYP2C9, CYP2C19, and CYP3A, with inhibition constant (Ki) values ranging from 0.08 to 5.88 µmol L⁻1. Initial predictions using a basic static model suggested potential for PDI, particularly with CYP2C9 substrates. To refine these predictions, a physiologically-based pharmacokinetic (PBPK) rat model was developed using mass balance studies and pharmacokinetic data across doses of 2 and 150 mg kg−1. The model's accuracy was confirmed by simulated versus observed maximum plasma concentration (Cmax) and area under the plasma concentration–time curve (AUC) values, with errors remaining within two-fold. The rat model was subsequently extrapolated to humans using in vitro binding and metabolism data. Simulations with 10 virtual trials, each involving 10 fasted human subjects, assessed PDI potential under multiple daily doses of PTC at multiples of the acceptable daily intake (ADI, 0.05 mg kg−1). AUC ratios for CYP3A (midazolam, nifedipine), CYP2C19 (omeprazole), and CYP2C9 (tolbutamide) substrates indicated no significant inhibition at ADI levels. This study underscores the safety of PTC in terms of PDIs at dietary exposure levels and highlights the utility of PBPK modeling as a robust tool for pesticide risk assessment. The findings strengthen confidence in PTC’s safety for human health.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2014/50945-4, 2020/02139-0, 2021/10098-4)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (306186/2021-7, INCT-DATREM - 465571/2014-0)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
This publication has 21 references indexed in Scilit:
- Why Prodrugs and Propesticides SucceedChemical Research in Toxicology, 2017
- In Vitro Inhibition of Human CYP450s 1A2, 2C9, 3A4/5, 2D6 and 2E1 by GrandisinPlanta Medica, 2017
- httk: R Package for High-Throughput Toxicokinetics2017
- Pesticide Chemical Research in Toxicology: Lessons from NatureChemical Research in Toxicology, 2016
- A cocktail approach for assessing the in vitro activity of human cytochrome P450s: An overview of current methodologiesJournal of Pharmaceutical and Biomedical Analysis, 2014
- Toxicokinetics and tissue distribution of prothioconazole in male adult Sprague-Dawley rats following a single oral administrationXenobiotica, 2014
- Evaluation of Various Static In Vitro–In Vivo Extrapolation Models for Risk Assessment of the CYP3A Inhibition Potential of an Investigational DrugClinical Pharmacology & Therapeutics, 2013
- From preclinical to human – prediction of oral absorption and drug–drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach in an industrial setting: a workflow by using case exampleBiopharmaceutics & Drug Disposition, 2012
- BINDING OF DRUGS TO HEPATIC MICROSOMES: COMMENT AND ASSESSMENT OF CURRENT PREDICTION METHODOLOGY WITH RECOMMENDATION FOR IMPROVEMENTDrug Metabolism and Disposition, 2006
- The Influence of Nonspecific Microsomal Binding on Apparent Intrinsic Clearance, and Its Prediction from Physicochemical PropertiesDrug Metabolism and Disposition, 2002